Tumor Immunotherapy
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
Cancer Therapies
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 13, 2025

A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Vishal Navani1, Daniel Y C Heng1
1Tom Baker Cancer Centre, Calgary, AB T2N 4N2, Canada; University of Calgary, Calgary, AB, Canada.
No abstract available in PubMed .
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
12:22The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013